Insider Selling: Denali Therapeutics Inc. (NASDAQ:DNLI) Director Sells 2,253 Shares of
Denali Therapeutics Inc. (NASDAQ:DNLI - Get Rating) Director Steve E. Krognes sold 2,253 shares of Denali ...
Read moreDenali Therapeutics Inc. (NASDAQ:DNLI - Get Rating) Director Steve E. Krognes sold 2,253 shares of Denali ...
Read moreEquities research analysts expect Denali Therapeutics Inc. (NASDAQ:DNLI – Get Rating) to announce earnings per share ...
Read more© 2022 TheDailyStock.News